Sign In

Login

Password

Forgot Password ? Sign Up

Nádorová imunologie (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nádorová imunologie" in Czech language version.

refsWebsite
Global rank Czech rank
27worldcat.org
5th place
3rd place
25doi.org
2nd place
4th place
24nih.gov
4th place
8th place
3sciencedirect.com
149th place
80th place
1cell.com
2,814th place
593rd place
1aacrjournals.org
8,869th place
8,116th place
1web.archive.org
1st place
1st place
1nature.com
234th place
72nd place
1wiley.com
222nd place
83rd place
1mdpi.com
2,912th place
482nd place
1frontiersin.org
4,679th place
990th place
1archive.org
6th place
10th place

aacrjournals.org

cancerimmunolres.aacrjournals.org

archive.org

cell.com

doi.org

dx.doi.org

doi.org

frontiersin.org

mdpi.com

  • QUARANTA, Valeria; SCHMID, Michael C. Macrophage-Mediated Subversion of Anti-Tumour Immunity. Cells. 2019/7, roč. 8, čís. 7, s. 747. Dostupné online [cit. 2020-01-31]. DOI 10.3390/cells8070747. (anglicky) 

nature.com

nih.gov

ncbi.nlm.nih.gov

  • SADELAIN, Michel; MILLER, Jacques F. A. P. The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy. Cancer Cell. 2015-04-13, roč. 27, čís. 4, s. 439–449. PMID: 25858803. Dostupné online [cit. 2019-02-08]. ISSN 1535-6108. DOI 10.1016/j.ccell.2015.03.007. PMID 25858803. (English) 
  • DUNN, Gavin P.; BRUCE, Allen T.; IKEDA, Hiroaki. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology. 2002-11, roč. 3, čís. 11, s. 991–998. PMID: 12407406. Dostupné online [cit. 2020-01-31]. ISSN 1529-2908. DOI 10.1038/ni1102-991. PMID 12407406. 
  • PANDOLFI, F.; CIANCI, R.; PAGLIARI, D. The immune response to tumors as a tool toward immunotherapy. Clinical & Developmental Immunology. 2011, roč. 2011, s. 894704. PMID: 22190975 PMCID: PMC3235449. Dostupné online [cit. 2019-02-08]. ISSN 1740-2530. DOI 10.1155/2011/894704. PMID 22190975. 
  • STORKUS, Walter J.; FINN, Olivera J.; DELEO, Albert. Categories of Tumor Antigens. Holland-Frei Cancer Medicine. 6th edition. 2003. Dostupné online [cit. 2019-02-08]. (anglicky) 
  • RAMOS, Carlos A.; NARALA, Neeharika; VYAS, Gayatri M. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2013-1, roč. 36, čís. 1, s. 66–76. PMID: 23211628 PMCID: PMC3521877. Dostupné online [cit. 2019-02-08]. ISSN 1537-4513. DOI 10.1097/CJI.0b013e318279652e. PMID 23211628. 
  • DISIS, M. L.; CHEEVER, M. A. Oncogenic proteins as tumor antigens. Current Opinion in Immunology. 1996-10, roč. 8, čís. 5, s. 637–642. PMID: 8902388. Dostupné online [cit. 2019-02-08]. ISSN 0952-7915. PMID 8902388. 
  • FINN, Olivera J. Human Tumor Antigens Yesterday, Today, and Tomorrow. Cancer Immunology Research. 2017-05-01, roč. 5, čís. 5, s. 347–354. PMID: 28465452. Dostupné online [cit. 2019-02-08]. ISSN 2326-6066. DOI 10.1158/2326-6066.CIR-17-0112. PMID 28465452. (anglicky) 
  • ORELL, S. R.; DOWLING, K. D. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions. Acta Cytologica. 1983-11, roč. 27, čís. 6, s. 625–629. PMID: 6196931. Dostupné online [cit. 2019-02-08]. ISSN 0001-5547. PMID 6196931. 
  • HSIEH, M. Y.; LU, S. N.; WANG, L. Y. Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization. Journal of Gastroenterology and Hepatology. 1992-11, roč. 7, čís. 6, s. 614–617. PMID: 1283085. Dostupné online [cit. 2019-02-08]. ISSN 0815-9319. PMID 1283085. 
  • KHOO, S. K.; MACKAY, E. V. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs. British Journal of Obstetrics and Gynaecology. 1976-10, roč. 83, čís. 10, s. 753–759. PMID: 990213. Dostupné online [cit. 2019-02-08]. ISSN 0306-5456. PMID 990213. 
  • WANG, Bei; ZAIDI, Neeha; HE, Li-Zhen. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Research. 2012-03-07, roč. 14, čís. 2, s. R39. Dostupné online [cit. 2019-02-08]. ISSN 1465-542X. DOI 10.1186/bcr3135. PMID 22397502. 
  • LI, Gordon; WONG, Albert J. EGF receptor variant III as a target antigen for tumor immunotherapy. Expert Review of Vaccines. 2008-9, roč. 7, čís. 7, s. 977–985. PMID: 18767947. Dostupné online [cit. 2019-02-08]. ISSN 1744-8395. DOI 10.1586/14760584.7.7.977. PMID 18767947. 
  • WEON, Jenny L; POTTS, Patrick Ryan. The MAGE protein family and cancer. Current Opinion in Cell Biology. 2015-12-01, roč. 37, čís. Differentiation and disease, s. 1–8. Dostupné online [cit. 2019-02-08]. ISSN 0955-0674. DOI 10.1016/j.ceb.2015.08.002. PMID 26342994. 
  • MITTAL, Deepak; GUBIN, Matthew M; SCHREIBER, Robert D. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape. Current Opinion in Immunology. 2014-04-01, roč. 27, čís. Lymphocyte development * Tumour immunology, s. 16–25. Dostupné online [cit. 2019-02-08]. ISSN 0952-7915. DOI 10.1016/j.coi.2014.01.004. PMID 24531241. 
  • VON BOEHMER, Lotta; MATTLE, Muriel; BODE, Peter. NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity. 2013, roč. 13, s. 12. PMID: 23882157 PMCID: PMC3718732. Dostupné online [cit. 2019-02-08]. ISSN 1424-9634. PMID 23882157. 
  • DANIYAN, Anthony F.; BRENTJENS, Renier J. Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies. Nature Reviews. Clinical Oncology. 2017-6, roč. 14, čís. 6, s. 333–334. PMID: 28397826 PMCID: PMC5536112. Dostupné online [cit. 2019-02-08]. ISSN 1759-4782. DOI 10.1038/nrclinonc.2017.49. PMID 28397826. 
  • TIRAPU, Iñigo; HUARTE, Eduardo; GUIDUCCI, Cristiana. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Research. 2006-02-15, roč. 66, čís. 4, s. 2442–2450. PMID: 16489051. Dostupné online [cit. 2019-02-08]. ISSN 0008-5472. DOI 10.1158/0008-5472.CAN-05-1681. PMID 16489051. 
  • PETTIT, S. J.; ALI, S.; O'FLAHERTY, E. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro. Clinical and Experimental Immunology. 1999-4, roč. 116, čís. 1, s. 48–56. PMID: 10209504 PMCID: PMC1905215. Dostupné online [cit. 2019-02-08]. ISSN 0009-9104. DOI 10.1046/j.1365-2249.1999.00857.x. PMID 10209504. 
  • CEPPI, P.; PATTANAYAK, A.; PUTZBACH, W. The role of CD95 and CD95 ligand in cancer. Cell Death and Differentiation. 2015-04, roč. 22, čís. 4, s. 549–559. Dostupné online [cit. 2019-02-08]. ISSN 1476-5403. DOI 10.1038/cdd.2015.3. PMID 25656654. (anglicky) 
  • BUCHBINDER, Elizabeth I.; DESAI, Anupam. CTLA-4 and PD-1 Pathways. American Journal of Clinical Oncology. 2016-2, roč. 39, čís. 1, s. 98–106. PMID: 26558876 PMCID: PMC4892769. Dostupné online [cit. 2020-01-31]. ISSN 0277-3732. DOI 10.1097/COC.0000000000000239. PMID 26558876. 
  • FRENZEL, Anna; GRESPI, Francesca; CHMELEWSKIJ, Waldemar. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis : an international journal on programmed cell death. 2009-4, roč. 14, čís. 4, s. 584–596. PMID: 19156528 PMCID: PMC3272401. Dostupné online [cit. 2020-01-31]. ISSN 1360-8185. DOI 10.1007/s10495-008-0300-z. PMID 19156528. 
  • HA, Tai-You. The Role of Regulatory T Cells in Cancer. Immune Network. 2009-12-01, roč. 9, čís. 6, s. 209–235. Dostupné online [cit. 2019-02-08]. ISSN 1598-2629. DOI 10.4110/in.2009.9.6.209. PMID 20157609. (English) 
  • BRUNNER-WEINZIERL, Monika C.; RUDD, Christopher E. CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy. Frontiers in Immunology. 2018-11-27, roč. 9. PMID: 30542345 PMCID: PMC6277866. Dostupné online [cit. 2020-01-31]. ISSN 1664-3224. DOI 10.3389/fimmu.2018.02737. PMID 30542345. 
  • FEINS, Steven; KONG, Weimin; WILLIAMS, Erik F. An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer. American Journal of Hematology. 2019-05, roč. 94, čís. S1, s. S3–S9. PMID: 30680780. Dostupné online [cit. 2020-01-31]. ISSN 1096-8652. DOI 10.1002/ajh.25418. PMID 30680780. 

sciencedirect.com

  • WEON, Jenny L; POTTS, Patrick Ryan. The MAGE protein family and cancer. Current Opinion in Cell Biology. 2015-12-01, roč. 37, čís. Differentiation and disease, s. 1–8. Dostupné online [cit. 2019-02-08]. ISSN 0955-0674. DOI 10.1016/j.ceb.2015.08.002. PMID 26342994. 
  • MITTAL, Deepak; GUBIN, Matthew M; SCHREIBER, Robert D. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape. Current Opinion in Immunology. 2014-04-01, roč. 27, čís. Lymphocyte development * Tumour immunology, s. 16–25. Dostupné online [cit. 2019-02-08]. ISSN 0952-7915. DOI 10.1016/j.coi.2014.01.004. PMID 24531241. 
  • VINAY, Dass S.; RYAN, Elizabeth P.; PAWELEC, Graham. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Seminars in Cancer Biology. 2015-12-01, roč. 35, čís. A broad-spectrum integrative design for cancer prevention and therapy, s. S185–S198. Dostupné online [cit. 2020-01-31]. ISSN 1044-579X. DOI 10.1016/j.semcancer.2015.03.004. (anglicky) 

web.archive.org

wiley.com

onlinelibrary.wiley.com

  • MANTOVANI, Alberto. The growing diversity and spectrum of action of myeloid-derived suppressor cells. European Journal of Immunology. 2010, roč. 40, čís. 12, s. 3317–3320. Dostupné online [cit. 2020-01-31]. ISSN 1521-4141. DOI 10.1002/eji.201041170. (anglicky) 

worldcat.org